Institute for OneWorld Health | Wikipedia audio article
Path. Is an international. Nonprofit global. Health organization. Based in Seattle, with, 1,600. Employees in, more than 70, plus offices, around the world its. President, and CEO is, Steve Davis, path. Focuses. On five platforms. Vaccines. Drugs. Diagnostics. Devices. And system, and service, innovations. To. Develop innovations. And implement, solutions that, save lives and improve health especially among, women and girls. Pa. Th's. Tagline, is better health moves, humanity, forward. Topic. History, founded, in 1977. With a focus, on family, planning path, soon broadened, its purpose, to work on a wide array of emerging and persistent, global, health issues, in the areas, of health technologies. Maternal. Health child, health reproductive, health, vaccines. And immunization. And emerging. And epidemic, diseases such, as HIV malaria. And, tuberculosis. Since. 2000. Path expanded. From about 300, employees and, an annual budget, of 60 million dollars to in 2016. A payroll of, 1,600. People working, in 70, plus countries and, a budget of 305. Million dollars, path. Is one of the largest nonprofit. Organizations. In global health today pa ths, headquarters, are in the South Lake Union Seattle. Neighborhood close, to several other global, health organizations. Including. The Bill and Melinda Gates Foundation. Topic. Institute. For one world health. One. World health was a 501. C, 3 non-profit, drug. Development, organization. Founded, in San Francisco. In 2000. By Victoria, Hill in. December, 2011 one, world health became, a drug development, program of path, what. Was the Institute, for one world health has become PA ths, drug development, program. Topic. PA, th's. Work. Pa, th's. Vision, is a world, where, innovation. Ensures, that health, is within reach for everyone. Its. Mission, is to improve. The health of people around the world by, advancing. Technologies. Strengthening. Systems, and encouraging. Healthy behaviors. Path. Is best known for developing and, adapting, technologies. Such, as improved, vaccination. Devices, and new tools to prevent cervical cancer. To address the health needs of developing, countries, it. Targets, health problems, evaluates. Possible, solutions, and assesses. Whether they would be useful in finding health solutions Steve. Davis, PA th's, CEO has, described, the organization's. Role as a bridge builder and innovator, on the global stage. Topic. Health, technologies. Path, develops, adapts. And advances. Technologies, focused, on disease Diagnostics. Drugs, vaccine. Delivery, nutrition. Reproductive. Health water and sanitation, and other areas. Topic. Vaccine. And pharmaceutical. Technologies. One. Of PA th's. Best known technologies. Is the vaccine vial monitor, a small, sticker that adheres, to a vaccine vial and changes, color as the vaccine is exposed, to heat over time, the. Sticker helps, health workers, know when a vaccine, has reached its preset, temperature, limit and can no longer be safely, used, it.
Promotes, More reliable, vaccinations. As well as cost savings, because health, workers, no longer have to throw out vaccine. Just because they suspect, it has gone bad. UNICEF. Requires, these monitors, on all vaccines, it purchases, another, vaccine technology. Developed, by path is the uniject, injection, system, the. Single, dose auto disabling. Injection, system, consists. Of a needle attached, to a small bubble of plastic, that is prefilled, with medication. The. System, is designed to, prevent disease transmission, and enable, health workers, with only a little training, to administer vaccine. And other drugs in remote villages. Topic. Nutrition. Path, develops, nutrition. Focused, innovations. Such as ultra, rice a manufactured. Micronutrient. Fortified, grain. That. Can be mixed with rice to fight malnutrition in, countries, where rice is a staple food. Made. Of rice flour. Micronutrients. And nutrient. Protecting, ingredients, Ultra rice can mimic the look and taste of local rice and deliver the specific, micronutrients. A population, needs. Ultra. Rice has been produced, and tested in several countries, including. Brazil Burundi, and India, where it has been served in school lunch programs. Half. Is working, with partners in Cambodia, to distribute, ultra rice through food assistance programs. And deepen the evidence, base for rice fortification. In. Brazil, path has partnered, with a commercial, rice producer. To sell ultra rice on supermarket, shelves and, reach 10 million low-income consumers in, three years. Topic. Sexual. And reproductive health. Several. Paths technologies. Address, sexual, and reproductive health. Including. The. Care HPV. Test developed. In conjunction with, key organ as the first molecular, diagnostic. To screen for human, papillomavirus. HPV the. Most, common cause of cervical cancer. In, clinics, in low resource settings. China's. State Food and Drug Administration approved. The, test for sale beginning, in January, 2013, followed. By India, and other emerging, markets, the. Test is designed specifically. For use, in clinics, that lack reliable, clean water or electricity. The. SILC, s diaphragm. One. Size fits, most. Contraceptive. Device the, device differs. From traditional latex. Diaphragms. In that it is made of silicone instead, of latex, is designed, to hold up to extreme, temperatures. And poor storage, conditions common, in developing, countries, and will not require a doctor's fitting. The. Woman's condom, a new female, condom, designed, to be more acceptable, to both partners, than other female, condoms, plus easier to use more, secure, less noisy, and more comfortable. Path. Transferred. Production, of the condom, - dahua medical, apparatus company. In China in 2008. The. Condom, has received, regulatory. Approvals, in China and the European Union and, became commercially. Available in, China in late 2011, path, employs, a user, driven design process. For its reproductive, technologies. To meet woman's specific, needs. Topic. Water, and sanitation. Path, looks, at ways to improve water quality in, developing, countries, including helping. Companies develop. Low-cost filters, gadgets. And other water treatment, products, to stimulate, a commercial. Market and keep prices low. Topic. Vaccines. And immunization. Path, is working, with biotechnology. And pharmaceutical companies. To, support the development of vaccines for diseases such. As meningitis. And pneumonia and. To help countries introduce. Vaccines, for childhood, illnesses, such as rotavirus. And Japanese, encephalitis. Topic. Meningitis. Path, and the World Health Organization. Through the meningitis, vaccine project, led the development of a vaccine called men of Rivet to end meningitis. Epidemics. In sub-saharan. Africa, where 450. Million people in, 26. Countries are, at risk of the disease, the. Vaccine, was developed by serum, Institute, of India and introduced, in Burkina Faso, Mali and Niger in, December, 2010, to prevent the spread of a strain of meningitis found. Only in Africa, within. Six months the vaccine, eliminated.
New Cases of meningitis er in the areas where it was introduced, by the, end of 2012, the vaccine, had reached 100. Million people in 10 countries Benin, Burkina Faso, Cameroon. Chad, Ghana, Mali, Niger. Nigeria. Senegal. And Sudan. The. Introduction. Of men of Rivet marked, the first time that a vaccine, was developed for a disease only found in Africa previously. Used meningitis. Vaccines, had low efficacy and cost USD, $80, per dose the. New vaccine, has high efficacy against. The type of meningitis that, is most prevalent in Africa, and costs less than 50, cents per dose, the. Entire vaccination. Research, and development, project, cost less than 100, million dollars about, one-fifth, the typical, cost for developing, a vaccine in 2012. Men of friv ik was also approved for storage, without refrigeration. For up to four days enabling. Health workers, to more easily reach, patients in, rural villages or in areas with no power. Topic. Rotavirus. Path, supports. The introduction. Of vaccines, against rotavirus in. Developing, countries, to protect, young children, from severe diarrhea, in. 2006. Path helped Nicaragua, become the first developing, country, to introduce, rotavirus. Vaccines, within months of their introduction. Former. Path researcher. John whacker noted, that rotavirus. Infections, dropped in areas, that began to use the vaccine after, the who recommended, its international. Use in 2009. Path also conducts, research to, show the impact, of rotavirus, vaccines, and help countries choose, whether to adopt the vaccines, into their immunization. Programs. Topic. Japanese. Then careful itis. Path, is working, with India and other countries in, the region to, introduce, an affordable, vaccine, to protect against, Japanese, encephalitis, a, disease. The World Health Organization. Estimates claims, 10,000. To 15,000. Lives a year mostly, children and causes, permanent, brain damage in. Many more in. 2006. Path helped, the Government of India launch an immunization, campaign. To reach millions of children, in high-risk, areas with the vaccine, path. Has also supported. Successful. Immunization. Campaigns, in Cambodia. North Korea, and other countries to reach more than 60, million children. Topic. Epidemic. Diseases. Part, of pata, Ches work focuses. On some of the most widespread and, threatening, global, diseases, malaria. Hiv/aids. Tuberculosis. And. Influenza. Topic. Malaria. The. Path malaria, vaccine, initiative supports. Several malaria, vaccine, candidates, at various, stages of development around. The world including the, most advanced candidate. Called RT s s. Researchers. Are studying RTS, s made, by, GlaxoSmithKline. In phase three clinical trials. Among infants, and young children in, sub-saharan. Africa. Interim. Results of the study released, in 2011, showed. The vaccine, provided, about 50%, protection, against malaria for, young children ages, 5, to 17, months. Interim. Study results, released in 2012, showed RTS, S reduced, cases, of malaria among, infants, by, 33%, in. October, 2013. Black so SmithKline reported, that the experimental. Vaccine, reduced, the number of cases amongst. Young children, by almost 50%, and, among infants, by around 25%. Following. The conclusion of an 18-month, clinical, trial. GlaxoSmithKline. Is set to submit an application for, a marketing, license, with the European, Medicines Agency. EEMA in 2014. The. New vaccine, has the backing of the UN Swiss base - which states that it will recommend the use of RTS, s for, use starting, in 2015. Providing. It gets approval another, path initiative, to address malaria. Is the malaria, control and, evaluation, partnership, in Africa, ma C EPA, which, focuses, on controlling, malaria through. The use of insecticide. Treated bed nets indoor. Spraying of insecticides. New, diagnostic. Tools to find infection. And effective, medicines, for treatment, in. Zambia, this work has helped decrease the rate of malaria, among children younger than age 5 by 50%, in, two years in December, 2012, path received, an award from, the u.s. president's, malaria initiative for. A new malaria, project, focused, on the, expansion, of high quality diagnosis. And treatment, for malaria and other childhood. Illnesses, and infection, diseases. PA. Th's. Drug development, program which, grew out of an affiliation, with one World Health is advancing. A new semi synthetic form, of the malaria drug artemisinin that.
Will Bolster the current volatile, botanical. Supply in. August, 2014, path, and Sanofi announced, the release of the first batch of semi, synthetic artemisinin. 1.7. Million doses of Sanofi, s artesian, atomo da King Winthrop, a saq, Winthrop, a fixed, dose artemisinin. Based, combination. Therapy, will be shipped to half a dozen African. Countries, over the next few months. Topic. HIV. Path, works, in Africa, Asia and, other regions, to slow the spread of hiv/aids. And, provide support, for people affected by the disease, in. Kenya, where path has worked for more than 20, years the, organization, conducts. Research into. Multi-purpose. Prevention. Technologies. That. Can protect women, from HIV, in pregnancy, and provides support, groups and health services, for married, adolescents. And other groups at high risk for HIV. It. Also leads, a large project, with local, governments, and community, organizations. To strengthen, and expand, services, for hiv/aids. Malaria, tuberculosis. And. Maternal. And newborn health other path projects. To address HIV, in Africa include. Improving, access to HIV treatment. And services, in Ethiopia. And expanding, HIV, counseling and, testing and, other services. In the Democratic, Republic of Congo path. Uses behavior, change communication, techniques. To encourage, healthy behaviors for, HIV, prevention, one. Of the best-known examples. Is pata chess work with magnet. Theatre, in, Kenya, India Vietnam, and, other developing, countries, named. Because of its natural pulling, power this interactive, street theatre draws people, in rural communities to. Clearings, dirt roads and village, centers, any open. Space where people can, gather their. Actors, banter, with their audiences. And pull them into the play stimulating. Dialogue about hiv/aids. And, other taboo, subjects. And helping individuals. Reexamine. Behaviors, that contribute to, poor health. Topic. Maternal. And child health. In, addition, to its work on vaccines, for childhood, illnesses, path addresses, pregnancy, complications. Nutrition. Issues and other health challenges, that affect women and children, in developing countries and lead to higher rates of illness and death, in, 2012. Paths completed. A seven-year, project in India focused, on safe birth for mothers and babies. Path. Worked with local governments. And community, groups to encourage community. Leaders, health, workers, pregnant, women and families. To deliver babies in health, centers rather, than at home and adopt, other best practices, to protect mothers, and their infants, during, pregnancy, childbirth, and, infancy. The. Project, used community, outreach approaches. Including, door-to-door. Clinical, surveillance, distribution. Of printed, health materials and, Street Theatre to spread messages about maternal, and newborn health in South Africa, path leads a five-year, project to, improve the health and development of. 750,000. Pregnant, women and children by encouraging, breastfeeding. And improving health care for pregnant women and young children. Topic. Where, path works. Headquartered. In Seattle Washington path, has more than 70, offices, in countries, around the world as, of. December, 2012, these countries, included, Belgium, Cambodia. China, Democratic. Republic, of Congo Ethiopia. France. Ghana, India, Kenya, Mozambique, Peru. Senegal. South, Africa, Switzerland. Tanzania. Thailand. Uganda. Ukraine, United States, Vietnam. And Zambia. Path. Currently, works in more than 70, countries. Topic. Funding. And expenses. Pa th's. Expenses. In 2011. Were, 284. Million dollars of which more than 40% was, spent on vaccines, and immunization. Programs, and 26%. Spent. On emerging, and epidemic, diseases path receives, funding, from foundations the. US government, other governments. Non-governmental. Organisations. Multilateral. Agencies. And individuals. PA. Ths, budget, for 2012, was us, 305. Million dollars, in 2010. Path received, the most US Foundation, grants in the state of Washington, and ranked 13th, among international, recipients.
Of Us foundation, grants Charity, Navigator, America's. Largest, independent. Evaluator, of nonprofits, has awarded, path, its highest rating, for stars for sound fiscal management for, nine consecutive years. Topic. Controversies. In, 2012. The NGO was warned, by the Indian, government after. One of its studies, involving, an HPV, vaccine. Resulted. In the alleged death of seven girls belonging to an indigenous community tribe. In India, in. What the Hindu called a shockingly. Unethical. Trial, nearly. 2800. Consent. Forms, were signed by a hostel, warden or headmaster. As the guardian. Topic. Recognition. In, 2012. Path was ranked as the sixth best NGO, in the world on the top, 100. List. Published, by the global, journal in 2009. Path, received, the Conrad N Hilton humanitarian. Prize for, five years running Fast, Company, magazine has. Named path as one of the top social entrepreneurs. Who are changing the world in, 2003. Path received, the tech museum's dr., Alejandro safar. Any health award for its work on the uniject, device a sterile, prefilled, single-use. Syringe, as of 2017. Path has been vetted and is in good standing as, part of global givings, Gigi rewards, program, since, 2005. Path, has remained on Forbes, top 200, list of the 200 largest. Charities in America. Topic. Board of directors, Joe addy MBA. MPA. Founder. And managing, director elsewhere, business, advantage, Dean Allen chair CEO, McKinstry. Phyllis, Campbell, MBA, chairman. Pacific, Northwest. JPMorgan. Chase & Co, Alex. Chicory, zdh. PhD. MSC. Executive. Director, African, population. And Health Research Center George cots as a MD, PhD. Director. Horatio. International, Foundation Peggy. Johnson executive. Vice president, Microsoft. David, King JD treasurer. Chairman, and CEO LabCorp. Gary Locke JD, former. Governor, of Washington State. Former US Secretary of State for, commerce former. US ambassador to, China sit, see mercy were MBA, co-founder. And executive chair. Higher life foundation, Bruce mcnamer, JD, MBA, acting. Vice chair, CEO, president, community. Foundation, for the National Capital. Region Lori Michaels, PhD. Founder. And CEO open. Road Alliance, Felix, Al Ahly MD, ph.d, secretary. Partner, leapfrog, investments. Deanna Oppenheimer, founder, cameo, works LLC. Kevin reilly mba, former. President, worth vaccines. And nutrition. Matt's PhD. Former, vice president, of infectious, disease, research and, animal health Merck & Co Inc. Peter. Smith CBE. DSC. FME, DSCI, professor. MRC. Tropical, epidemiology. Group London, School of Hygiene and. Tropical Rajendra. Vitarka T M s founder. And former president. And CEO Co Vance's founder, vatika T Foundation, arena vittle MBA, former. Partner, McKinsey. & Company yeh, Hong Jang PhD. MBA, CEO. Lui, a pharmaceutical. Group, international. Topic. C also. Philanthropy. Concept. Foundation. Reproductive. Health supplies, coalition. GA. VI Alliance. Global. Health. Zika. Virus.